BF

BrightEdge Fund

Investments

  • Paradigm

    NYC company founded in 2022 by Jonathan Hirsch and Kent Thoelke, running a technology platform that expands patient participation in clinical trials and improves trial efficiency.

Something wrong or missing? Send an update. Fixed within 24 hours.